What is the current arteriovenous fistula treatment market size?

The arteriovenous fistula treatment market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the arteriovenous fistula treatment market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the arteriovenous fistula treatment market?

Key drivers include rising prevalence of cardiovascular diseases and growing awareness of treatment options.

What are the major challenges facing the arteriovenous fistula treatment market?

Challenges include high treatment costs and limited availability of skilled healthcare professionals.

Which regions are expected to lead the arteriovenous fistula treatment market?

North America and Europe are expected to be regional leaders due to advanced healthcare infrastructure.

Who are the top companies in the arteriovenous fistula treatment market?

Top companies include Medtronic, Boston Scientific, and Abbott, which offer a range of treatment products.

What future opportunities exist in the arteriovenous fistula treatment market?

Future opportunities include development of minimally invasive treatments and expansion into emerging markets.

How will technology impact the arteriovenous fistula treatment market?

Advances in technology will improve treatment outcomes and enhance patient experience, driving market growth.

What is the current regulatory landscape for the arteriovenous fistula treatment market?

The regulatory landscape is evolving, with a focus on ensuring patient safety and efficacy of treatment products.

Which Companies Lead the arteriovenous fistula treatment Market in 2026?

arteriovenous fistula treatment by Application (Drugs, Transcatheter Embolization, Ultrasound-guided Compression, Surgery), by Types (Dural Arteriovenous Fistulas, Peripheral Arteriovenous Fistulas, Pial or Cerebral Arteriovenous Fistulas) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $4200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $4200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

arteriovenous fistula treatment Market Overview

The arteriovenous fistula treatment market refers to the medical interventions used to treat abnormal connections between arteries and veins. As the global population ages and the prevalence of vascular diseases increases, the arteriovenous fistula treatment market size is estimated to be around $1.4 billion. The growth outlook for this market is promising, with a market forecast that indicates a significant expansion over the next decade. The industry expansion will be driven by advancements in minimally invasive procedures, endovascular treatments, and vascular surgery, which are expected to shape the future of arteriovenous fistula treatment. The scope of this market encompasses various synonyms, including vascular malformation treatment, arteriovenous malformation treatment, and fistula repair.

Loading chart…

The arteriovenous fistula treatment market is expected to grow at a CAGR of 7.5% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of vascular diseases, advancements in medical technology, and rising healthcare expenditure. Key forces shaping the industry include technology shifts towards minimally invasive procedures, regulations governing medical device approvals, and competitive intensity among market players. The largest region in the arteriovenous fistula treatment market is North America, while the fastest-growing region is Asia-Pacific. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to make strategic decisions and stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 billion
Revenue forecast in 2033	10.47 billion
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Becton Dickinson; Medtronic; B. Braun; Cook Medical; Teleflex Incorporated; Fresenius Medical Care; NxStage Medical; Poly Medicure
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The arteriovenous fistula treatment market is poised for significant growth, driven by increasing demand for minimally invasive procedures and advancements in medical technology. The arteriovenous fistula treatment market size is expected to expand substantially, with a growth forecast that indicates a promising future for industry players.

Growth Drivers2 items

Advances in catheter-based technologies have improved the efficacy and safety of arteriovenous fistula treatments, driving adoption rates and contributing to the growth of the arteriovenous fistula treatment market

The increasing prevalence of chronic kidney disease and end-stage renal disease has led to a rising demand for dialysis access procedures, further fueling the growth of the arteriovenous fistula treatment market size

Restraints2 items

High costs associated with arteriovenous fistula treatments and the need for repeated interventions can limit access to these procedures, thereby constraining the growth forecast of the arteriovenous fistula treatment market

Stringent regulatory requirements and the need for clinical evidence to support the efficacy of new treatments can hinder innovation and slow the growth of the arteriovenous fistula treatment market

Opportunities2 items

The development of novel arteriovenous fistula treatments, such as bioengineered grafts, presents opportunities for industry players to expand their product portfolios and capitalize on the growing demand for innovative solutions

Emerging markets in Asia-Pacific and Latin America offer significant growth potential for the arteriovenous fistula treatment market, driven by increasing healthcare expenditure and improving access to dialysis services

Challenges2 items

The arteriovenous fistula treatment market faces challenges related to reimbursement and pricing, particularly in regions with limited healthcare resources, which can impact the growth forecast and market size

The need for skilled healthcare professionals to perform complex arteriovenous fistula procedures can create barriers to access, particularly in rural or underserved areas, and hinder the growth of the arteriovenous fistula treatment market

Market Segmentation

Loading chart…

The arteriovenous fistula treatment segmentation can be categorized based on application, which includes dialysis and other applications. The dialysis segment holds a significant share of the market, driving the growth of the arteriovenous fistula treatment market size. This is due to the increasing prevalence of end-stage renal disease (ESRD) and the rising demand for dialysis procedures.

In terms of types, the arteriovenous fistula treatment market can be segmented into arteriovenous fistula creation and arteriovenous fistula repair. Arteriovenous fistula creation involves the surgical creation of a fistula, while arteriovenous fistula repair involves the treatment of existing fistula-related complications. Understanding these subtypes is crucial for market taxonomy, as it helps in identifying the specific needs of patients and healthcare providers, ultimately contributing to the overall arteriovenous fistula treatment market size.

arteriovenous fistula treatment Segmentation Breakdown9 items

Application

Drugs

Transcatheter Embolization

Ultrasound-guided Compression

Surgery

Types

Dural Arteriovenous Fistulas

Peripheral Arteriovenous Fistulas

Pial or Cerebral Arteriovenous Fistulas

Regional Insights

Loading chart…

The arteriovenous fistula treatment market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be the Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - ecosystem maturity, high demographics awareness, and established infrastructure; Europe - regional forecast indicating steady growth, increasing adoption of minimally invasive procedures, and favorable policies; Asia Pacific - large demographics, rapid infrastructure development, and growing adoption of advanced medical technologies; Latin America - increasing investments in healthcare, rising adoption of new treatments, and improving infrastructure; Middle East & Africa - growing demographics, rising adoption of advanced medical technologies, and increasing investments in healthcare.

The arteriovenous fistula treatment market is expected to experience significant growth in the coming years, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure. Understanding the regional dynamics and key drivers is crucial for stakeholders to capitalize on the emerging opportunities and navigate the complex regional forecast.

Competitive Landscape

The arteriovenous fistula treatment market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The arteriovenous fistula treatment competitive landscape is characterized by high competition, with companies focusing on differentiating themselves through innovative products and services.

Common strategies employed by key players include M&A, partnerships, product launches, expansion, R&D, and localization. Companies aim to differentiate themselves through technology, service model, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to stay competitive, as seen in the following company strategies:

Becton Dickinson: regional expansion

Medtronic: innovation pipeline

B. Braun: premium pricing

Cook Medical: OEM tie-ups

Teleflex Incorporated: vertical integration

Fresenius Medical Care: local manufacturing

Key arteriovenous fistula treatment Companies8 items

Becton Dickinson

Medtronic

B. Braun

Cook Medical

Teleflex Incorporated

Fresenius Medical Care

NxStage Medical

Poly Medicure

Market Ecosystem

The arteriovenous fistula treatment ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, midstream, and downstream, with value created and captured at each stage. Upstream participants, such as technology providers and raw material suppliers, provide the foundational elements for arteriovenous fistula treatment solutions. Midstream participants, including manufacturers and system integrators, assemble and refine these elements into finished products. Downstream participants, comprising distributors, service providers, and end users, ultimately deliver and utilize these products.

Raw material/component suppliers — providing critical materials

OEMs / manufacturers — producing medical devices

Technology providers — developing innovative treatments

System integrators / EPCs — integrating treatment solutions

Distributors / channel partners — delivering products to market

Service providers / after-sales — offering support and maintenance

End users / buyers — utilizing arteriovenous fistula treatment products

Within the arteriovenous fistula treatment ecosystem, control points are primarily held by regulatory bodies, such as regulators and standards bodies, which influence adoption through approvals and compliance requirements. Dependency risks arise from input constraints, standards, and approvals, which can impact the availability and affordability of treatment solutions. Furthermore, switching costs, partnerships, and interoperability requirements can also affect the ecosystem, particularly in terms of value chain analysis. The ecosystem's dynamics can vary by region, with different areas having distinct regulatory frameworks, market conditions, and patient needs, ultimately shaping the arteriovenous fistula treatment ecosystem.

Recent Industry Insights

The arteriovenous fistula treatment industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed, such as collaborations between medical device manufacturers and healthcare providers, to improve patient outcomes. Mergers and acquisitions have also been observed, with companies like Medtronic and Becton Dickinson expanding their portfolios. Furthermore, innovative product launches have been introduced, including minimally invasive treatments and advanced vascular access devices. Regulatory changes have also played a crucial role, with the FDA approving new treatments and updating guidelines for arteriovenous fistula care. These developments have contributed to a shift in consumer and enterprise trends, with a growing focus on personalized medicine and value-based care.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the arteriovenous fistula treatment market. The market attractiveness is moderate, driven by an increasing prevalence of end-stage renal disease and a growing demand for minimally invasive procedures. The competitive intensity is high, with key players investing heavily in research and development to improve treatment outcomes.

The long-term arteriovenous fistula treatment market outlook is positive, with opportunities for innovation in catheter-based and surgical interventions. The demand-supply balance is expected to remain stable, with a steady growth in demand driven by an aging population and an increasing awareness of treatment options. Key risk factors include regulatory changes, reimbursement pressures, and the potential for complications and adverse events.

11 items

1. Executive Summary

2. arteriovenous fistula treatment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global arteriovenous fistula treatment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global arteriovenous fistula treatment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Drugs

6.1.2. Transcatheter Embolization

6.1.3. Ultrasound-guided Compression

6.1.4. Surgery

6.2. Global arteriovenous fistula treatment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Dural Arteriovenous Fistulas

6.2.2. Peripheral Arteriovenous Fistulas

6.2.3. Pial or Cerebral Arteriovenous Fistulas

6.3. Global arteriovenous fistula treatment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global arteriovenous fistula treatment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global arteriovenous fistula treatment Market by: Regions (Value)

8. Global arteriovenous fistula treatment Market Competition by Key Manufacturers

8.1. Global arteriovenous fistula treatment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global arteriovenous fistula treatment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Becton Dickinson

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Medtronic

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. B. Braun

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Cook Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Teleflex Incorporated

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Fresenius Medical Care

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. NxStage Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Poly Medicure

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global arteriovenous fistula treatment Market

Figure 4: Global arteriovenous fistula treatment Market: Drivers

Figure 5: Global arteriovenous fistula treatment Market: Challenges

Figure 6: Global arteriovenous fistula treatment Market: Trends

Figure 7: Global arteriovenous fistula treatment Market: Opportunity

Figure 8: Global arteriovenous fistula treatment Market: Restraint

Figure 9: Global arteriovenous fistula treatment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global arteriovenous fistula treatment Market Value (USD Million) By Region

Figure 15: Global arteriovenous fistula treatment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global arteriovenous fistula treatment Market Value (USD Million) By Region

Figure 23: Global arteriovenous fistula treatment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global arteriovenous fistula treatment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global arteriovenous fistula treatment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global arteriovenous fistula treatment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global arteriovenous fistula treatment Market Value (USD Million) By Region

Table 10: Global arteriovenous fistula treatment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global arteriovenous fistula treatment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global arteriovenous fistula treatment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global arteriovenous fistula treatment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Becton Dickinson Basic Information And Sales Area

Table 31: Becton Dickinson. Products Portfolio

Table 32: Medtronic Basic Information And Sales Area

Table 33: Medtronic. Products Portfolio

Table 34: B. Braun Basic Information And Sales Area

Table 35: B. Braun. Products Portfolio

Table 36: Cook Medical Basic Information And Sales Area

Table 37: Cook Medical. Products Portfolio

Table 38: Teleflex Incorporated Basic Information And Sales Area

Table 39: Teleflex Incorporated. Products Portfolio

Table 40: Fresenius Medical Care Basic Information And Sales Area

Table 41: Fresenius Medical Care. Products Portfolio

Table 42: NxStage Medical Basic Information And Sales Area

Table 43: NxStage Medical. Products Portfolio

Table 44: Poly Medicure Basic Information And Sales Area

Table 45: Poly Medicure. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global arteriovenous fistula treatment Market Value (USD Million) By Region

Table 51: Global arteriovenous fistula treatment Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

arteriovenous fistula treatment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 billion
Revenue forecast in 2033	10.47 billion
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Becton Dickinson; Medtronic; B. Braun; Cook Medical; Teleflex Incorporated; Fresenius Medical Care; NxStage Medical; Poly Medicure
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory requirements and the need for clinical evidence to support the efficacy of new treatments can hinder innovation and slow the growth of the arteriovenous fistula treatment market

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

arteriovenous fistula treatment Segmentation Breakdown9 items

Application

Drugs

Transcatheter Embolization

Ultrasound-guided Compression

Surgery

Types

Dural Arteriovenous Fistulas

Peripheral Arteriovenous Fistulas

Pial or Cerebral Arteriovenous Fistulas

Regional Insights

Loading chart…

Competitive Landscape

Becton Dickinson: regional expansion

Medtronic: innovation pipeline

B. Braun: premium pricing

Cook Medical: OEM tie-ups

Teleflex Incorporated: vertical integration

Fresenius Medical Care: local manufacturing

Key arteriovenous fistula treatment Companies8 items

Becton Dickinson

Medtronic

B. Braun

Cook Medical

Teleflex Incorporated

Fresenius Medical Care

NxStage Medical

Poly Medicure

Market Ecosystem

Raw material/component suppliers — providing critical materials

OEMs / manufacturers — producing medical devices

Technology providers — developing innovative treatments

System integrators / EPCs — integrating treatment solutions

Distributors / channel partners — delivering products to market

Service providers / after-sales — offering support and maintenance

End users / buyers — utilizing arteriovenous fistula treatment products

Recent Industry Insights

Analyst Overview

Table of Contents